Pancreatic cancer: a review of current treatment and novel therapies

HM Kolbeinsson, S Chandana, GP Wright… - Journal of Investigative …, 2023 - Taylor & Francis
… In summary, pancreatic cancer remains a disease with poor long-… pancreatic cancer
treatment and the milestones that brought us to where we are today, along with emerging therapies

Pasireotide: a novel treatment for tumor-induced hypoglycemia due to insulinoma and non-islet cell tumor hypoglycemia

M Siddiqui, A Vora, S Ali, J Abramowitz… - … of the Endocrine …, 2021 - academic.oup.com
… the pancreatic head, suspicious for a small insulinoma, but endoscopic ultrasound failed to
localize the tumor… any abnormal uptake concerning for neuroendocrine tumor, and a selective …

Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets

RP Czekay, DJ Cheon, R Samarakoon, SM Kutz… - Cancers, 2022 - mdpi.com
tumor survival [79]. Clarifying the impact of the dynamic CAF environment on tumor growth
and metastasis may inform novel treatment strategies targeting specific CAF populations. …

Novel therapeutic strategies for CDK4/6 inhibitors in metastatic castrate-resistant prostate cancer

AM Kase, JA Copland III, W Tan - OncoTargets and therapy, 2020 - Taylor & Francis
… combinatorial therapies with CDK4/6i’s. Table 1 shows mutated genes in mCRPC and
will be referred throughout this review in guiding novel combinatorial therapeutic strategies. …

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer

SR Pierce, Z Fang, Y Yin, L West, M Asher… - … & Clinical Cancer …, 2021 - Springer
cancer. These studies support DRD2 antagonism via ONC201 as a promising therapeutic
strategy for endometrial cancer … in both serous and endometrioid endometrial cancer patients. …

A precision medicine drug discovery pipeline identifies combined CDK2 and 9 inhibition as a novel therapeutic strategy in colorectal cancer

JA Somarelli, RS Roghani, AS Moghaddam… - … cancer therapeutics, 2020 - AACR
… is a useful platform to identify novel inhibitors. This platform led to the identification of dual
CDK2/9 inhibition as a promising therapeutic strategy to treat metastatic colorectal cancer. …

Targeted cancer therapy: what's new in the field of neuroendocrine neoplasms?

A La Salvia, P Espinosa-Olarte, MDC Riesco-Martinez… - Cancers, 2021 - mdpi.com
… Despite recent therapeutic achievements, thus, systemic treatment options remain … therapies
in the field of NETs, and also future perspectives of novel therapeutic drugs or strategies in …

Targeting PRAS40: a novel therapeutic strategy for human diseases

Q Zhou, S Tang, X Zhang, L Chen - Journal of Drug Targeting, 2021 - Taylor & Francis
… more and more attention, especially in the process of cancer. With its further studies, we
believe that PRAS40 can be used as a novel target for disease treatment and drug research. …

Homogeneous MMR deficiency throughout the entire tumor mass occurs in a subset of colorectal neuroendocrine carcinomas

C Fraune, R Simon, C Hube-Magg… - Endocrine …, 2020 - Springer
… , demanding novel treatment strategies such as immune checkpoint inhibition in tumors with
… of 10) but highly infrequent in neuroendocrine neoplasms from many other sites. The lack of …

The role of DLLs in cancer: a novel therapeutic target

MX Xiu, YM Liu, B Kuang - OncoTargets and therapy, 2020 - Taylor & Francis
… vasculature and tumor immunity, which play different roles in cancer progression. DLLs … as
anti-cancer therapeutics. In this review, we discuss the role of DLLs in cancer and summarize …